March 2026 in “Journal of Cancer Survivorship” Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.
March 2026 in “Journal of Hunan University Natural Sciences” Albizia saponaria stem bark shows promise as a natural antidandruff treatment.
February 2026 in “BMC Plastic and Reconstructive Surgery” Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.
Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.
October 2025 in “Indian Journal of Physiology and Pharmacology” Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.
June 2025 in “Journal of Endocrinological Investigation” Adrenal disorders often cause high blood pressure in young people.
March 2025 in “OncoTargets and Therapy” A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.
January 2025 in “Directory of Open access Books (OAPEN Foundation)” PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.
Polarized microscopy helps identify hair irregularities in genetic disorders.
October 2024 in “Irish Journal of Medical Science (1971 -)” Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.
July 2024 in “Journal of Rare Diseases” Woodhouse-Sakati syndrome shows varied symptoms and genetic differences within families.
July 2024 in “Journal Of Stem Cell Research” Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.
The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.
Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.
November 2023 in “Deleted Journal” Cedrus libani has potential medicinal uses but needs more safety studies.
Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.
January 2023 in “Pakistan Armed Forces Medical Journal”
January 2023 in “Book of Abstracts” The study investigated hair loss in 25 patients following COVID-19 infection, identifying various types of alopecia, with telogen effluvium (TE) being the most common. Five patients experienced acute TE, with hair loss starting a median of 2 months post-infection and lasting a median of 4 months. Fifteen patients had chronic TE, beginning a median of 6 months post-infection and lasting a median of 9 months. Additionally, five patients developed patchy alopecia areata (AA) 2-3 weeks after infection, with hair loss lasting a median of 10 months. The study highlighted that post-COVID hair loss could manifest in different alopecia types, with TE being the most prevalent.
January 2022 in “Dermatology Review” Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.
The workshop promoted better medicine use and health practices through global collaboration.
The workshop successfully promoted better medicine use and international collaboration.
October 2020 in “Veterinary Dermatology” New treatments and diagnostic methods for various animal skin conditions showed promising results.
July 2018 in “British Journal of Dermatology” Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.
March 2017 in “Fundamental & Clinical Pharmacology” The model and estimator can predict drug exposure in kidney transplant patients well.
January 2017 in “Clinical approaches and procedures in cosmetic dermatology” Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.
January 2017 in “Clinical approaches and procedures in cosmetic dermatology” Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.
January 2014 in “Side effects of drugs annual” Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.
January 2009 in “Side effects of drugs annual” Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.
January 2009 in “Springer eBooks” The document concludes that managing skin conditions during pregnancy is important and requires specialized care.
March 2008 in “Aging health” Docetaxel is safe and works well for older people with cancer, with manageable side effects.